Newsfeeds - Spark Newswire

2 minute read

Takeda Canada Announces LIVTENCITY Receives Positive CADTH Recommendation For Adults With Post-transplant Cytomegalovirus Infection

Today, 3:02 AM

Takeda Canada Inc. ("Takeda") is pleased to announce that the Canada's Drug and Health Technology Agency (CADTH) Canadian Drug Expert Committee (CDEC) recommends LIVTENCITY™ (maribavir) for

TAK

5 minute read

Takeda’s Biologics License Application For Dengue Vaccine Candidate, TAK-003, Granted Priority Review By U.S. FDA

By Benzinga Newsdesk

Today, 3:02 AM

- TAK-003 is Being Evaluated for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals 4 Years Through 60 Years of Age Takeda ((TAK) today announced that the U.S. Food and Drug

TAK

1 minute read

Takeda Announces Phase 3 Trial Of ICLUSIG Met Primary Endpoint In Newly-Diagnosed Ph+ ALL, A Setting With No Targeted Treatments Approved In The US

By Benzinga Newsdesk

Today, 3:02 AM

- The PhALLCON Study Is the First Global, Phase 3, Registrational, and Only Head-To-Head Clinical Trial Comparing Two TKIs in Frontline Ph+ ALL - Primary Endpoint Result Shows Superiority Compared to Imatinib as

TAK

18 minute read

Earnings

Earnings Scheduled For October 27, 2022

By Benzinga Insights

Today, 3:02 AM

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.

AAPL

25 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 3:02 AM

On Friday morning, 446 companies hit new 52-week lows.

ABG

12 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 3:02 AM

On Wednesday, 200 companies hit new 52-week lows.

AAN

1 minute read

Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids

By Vandana Singh

Today, 3:02 AM

The FDA has accepted Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) supplemental marketing application for the potential expanded use of TAKHZYRO (lanadelumab-flyo) for…

TAK

46 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 3:02 AM

Monday saw 825 companies set new 52-week lows.

$APE

1 minute read

News

Takeda Signs Virtual Power Purchase Agreement With Enel North America To Advance Renewable Energy Production In The United States

By Benzinga Newsdesk

Today, 3:02 AM

- 12-Year Agreement Prioritizes Environmental Stewardship to Help Create Clean Energy Solutions and Advances Progress Towards Net-Zero Greenhouse Gas (GHG) Emissions Targets - Agreement Expected to Create Up

TAK